Synapse elimination at the developing neuromuscular junction (NMJ) sculpts motor circuits, and synapse loss at the aging NMJ drives motor impairments that are a major cause of loss of independence in the elderly. Here we provide evidence that at the NMJ, both developmental synapse elimination and aging-related synapse loss are promoted by specific immune proteins, members of the major histocompatibility complex class I (MHCI). MHCI is expressed at the developing NMJ, and three different methods of reducing MHCI function all disrupt synapse elimination during the second postnatal week, leaving some muscle fibers multiply-innervated, despite otherwise outwardly normal synapse formation and maturation. Conversely, overexpressing MHCI modestly accelerates developmental synapse elimination. MHCI levels at the NMJ rise with aging, and reducing MHCI levels ameliorates muscle denervation in aged mice. These findings identify an unexpected role for MHCI in the elimination of neuromuscular synapses during development, and indicate that reducing MHCI levels can preserve youthful innervation of aging muscle.
Introduction
Synapse elimination sculpts mature patterns of connectivity throughout the vertebrate nervous system. During prenatal and early postnatal development, axons retract, refining initially diffuse projections. Consistent with a critical role in circuit maturation, defects in synapse elimination have been implicated in neurodevelopmental disorders (e.g., (Hayashi-Takagi et al., 2014; Krey et al., 2013; Noutel et al., 2011; Pfeiffer et al., 2010; Tang et al., 2014; Tsai et al., 2012) ). Synapse loss also occurs with aging, when it is associated with significant motor and cognitive impairments (reviewed in (Hedden and Gabrieli, 2004; Rudolf et al., 2014) ). However, the molecular drivers of developmental synapse elimination remain largely unknown. Furthermore, it is unclear if developmental synapse elimination and aging-related denervation occur through related, or distinct, molecular mechanisms.
The canonical model for studying developmental synapse elimination is the vertebrate neuromuscular junction (NMJ) (Brown et al., 1976; Thompson, 1985) . Before birth, each muscle fiber receives inputs from many motor neurons (MNs) (Nguyen and Lichtman, 1996; Sanes and Lichtman, 1999; Tapia et al., 2012) . MN axon branches are extensively pruned, and by the end of the second postnatal week in rodents, each muscle fiber receives input from only a single MN (Brown et al., 1976; Busetto et al., 2000; Keller-Peck et al., 2001; Redfern, 1970) .
Previous studies have significantly advanced our understanding of the factors that control the rate of synapse elimination. Several manipulations either delay (Je et al., 2013; Lee et al., 2011; Li et al., 2004; Misgeld et al., 2002; Nguyen et al., 1998; Personius et al., 2008; Rafuse et al., 2000; Roche et al., 2014; Sleigh et al., 2014; Thompson et al., 1979) or accelerate (Bogdanik et al., 2012; O'Brien et al., 1978; Personius et al., 2007; Thompson, 1983) synapse elimination at the developing NMJ. However, in most cases where synapse elimination is delayed, uniform monoinnervation is still established within the first few postnatal weeks. Thus the endogenous factors that ensure elimination of every excess MN input remain largely unknown. In adults, responses to peripheral motor neuron injury are regulated by specific immune proteins, members of the major histocompatibility complex, class I (MHCI). MHCI has been detected in adult motor neurons (Edstrom et al., 2004; Linda et al., 1999; Thams et al., 2009 ), but adult muscle cells are thought to represses MHCI genes, except after injury or in disease states (Karpati et al., 1988) . Consequently, studies of the role of MHCI in the peripheral nervous system have focused almost exclusively on responses to injury. In injury models, reducing MHCI expression exacerbates loss of synapses made onto axotomized motor neuron cell bodies in the spinal cord, and impairs functional recovery (Berg et al., 2013; Oliveira et al., 2004; Thams et al., 2009) . These and other studies have reinforced the view that at the NMJ, MHCI is primarily involved in responses to injury. In the central nervous system, MHCI has been implicated in pruning of developing retinal projections Huh et al., 2000; Lee et al., 2014) , while elimination of developing cerebellar climbing fibers is MHCIindependent (Letellier et al., 2008; McConnell et al., 2009 ). Here we explored if MHCI plays a role in developmental synapse elimination or aging-related synapse loss at the vertebrate NMJ.
Results

Impaired synapse elimination in mice deficient for cell-surface MHCI
MHCI genes are expressed at the NMJ as synapse elimination is occurring (Tetruashvily et al., in press ). If MHCI promotes synapse elimination at the developing NMJ, then reducing MHCI expression should increase the number of multiply-innervated muscle fibers. To test this prediction, we visualized innervation of postsynaptic sites in diaphragm muscle fibers from mice lacking stable cellsurface expression of most MHCI proteins (b2m
see Section 4). The diaphragm is a thin, planar muscle with a well-organized end plate band that is particularly amenable to imaging in whole-mount preparations. Postsynaptic nicotinic acetylcholine receptors (nAChRs) were labeled using tetramethyl rhodamine-conjugated a-bungarotoxin (a-btx), and presynaptic motor neuron axons were visualized using antibodies against the axon cytoskeletal element neurofilament and the presynaptic vesicle protein SV2. Because individual nAChR clusters may lay above one another in whole mount muscle, 3D reconstructions of confocal Z-stacks were created for all suspected multiply-innervated postsynaptic sites, and reconstructed stacks were viewed from multiple depths and angles to determine if motor neuron branches were distinct, and if they innervated a single nAChR cluster, or two clusters in different focal planes (see Section 4). In WT mice, nearly all postsynaptic sites are contacted by a single MN axon by postnatal day 15 (P15), as expected (Kopp et al., 2000; Redfern, 1970) . In contrast, significantly more postsynaptic sites remain multiply-innervated in mice lacking cell-surface MHCI (Fig. 1A-C . Multiple innervation at P15: b2m
, 16.4 ± 2.2%; WT, 3.5 ± 1.1%; p = 0.0011). Multiply-innervated postsynaptic sites detected in P15 MHCI-deficient mice all received two inputs. Although multiple innervation persists, b2m À/À TAP À/À mice are of normal size and weight, and eye opening, fur growth, weaning, and reproduction all occur at appropriate ages. Development of the NMJ is also otherwise outwardly normal. Every muscle fiber contains only a single postsynaptic nAChR cluster at P15, and the area, perimeter, and intensity of nAChR labeling, and morphology of the end plate band, are all normal in b2m Fig. S2) . Furthermore, the distribution of nAChR labeling changes as expected from plaque-like to pretzel-like as the animals matured. Despite this maturation, multiple innervation persists in MHCI-deficient adults ( Fig. 1A-C 
, 18.6 ± 4.3%; WT, 2.3 ± 1.7%; p = 0.0116), and remarkably, is still present at one year of age (Fig 1D; b2m
, 9.5 ± 1.3%; WT, 2.5 ± 0.5%; p = 0.0069). Thus loss of MHCI prevents multiple innervation from fully resolving at the NMJ.
Loss of MHCI could cause multiply-innervated muscle fibers to persist because it directly or indirectly disrupts synapse elimination, or because it increases synapse formation via changes in neurogenesis, programmed cell death, or motor neuron outgrowth or branching. However, several lines of evidence suggest that changes in synapse formation do not underlie the persistent multiple innervation in MHCI-deficient animals. At birth (P0) and at P7, when MN programmed cell death and synapse formation are largely complete Xu et al., 2006; Yamamoto and Henderson, 1999) , a normal proportion of postsynaptic sites are multiply-innervated in MHCI-deficient mice (Fig. 1A-C) . Furthermore, at P7, each muscle fiber is contacted by the same average number of axons in WT and MHCI-deficient mice ( Fig. S2E and  F) . Thus measures that are sensitive to changes in motor neuron and muscle fiber number and synapse formation are normal in MHCI-deficient mice. These results suggest that in the absence of MHCI, patterns of innervation are established normally, but innervation fails to decline over the second postnatal week, consistent with a disruption of developmental pruning. However, it is still possible that loss of MHCI prevents the establishment of monoinnervation without changes in synapse elimination, e.g., by prolonging neurogenesis, programmed cell death, and/or synapse formation well past their normal developmental window. If synapse elimination is not impaired in MHCI-deficient mice, then ongoing synapse formation would be necessary to explain the stable synapse density from P7 onwards. However, we did not see evidence of ongoing axon sprouting, outgrowth, or synapse formation over the second postnatal week. Together, these results suggest that changes in synapse formation are unlikely to contribute significantly to persistent multiple innervation in MHCI-deficient animals. Instead, they are more consistent with a role for MHCI in allowing synapse elimination to reach completion.
Extensive synapse elimination occurs at the NMJ prior to the close of the first postnatal week . This initial synapse elimination does not require MHCI, because at P7, the percentage of postsynaptic sites that remain multiply-innervated ( Fig. 1 ) and the extent of MN convergence onto individual postsynaptic sites (Fig. S2E and F) are both normal in MHCI-deficient mice. Consistent with the fact that early synapse elimination happens normally, MHCI-deficient mice do not display gross motor deficits (e.g., weakness, inactivity, or tremor) Nelson et al., 2013) . Over the second postnatal week, however, far fewer postsynaptic sites achieve mono-innervation in MHCI-deficient animals, a failure of circuit maturation that could disrupt the emergence of fine motor control. Remarkably, there is no further decline in multiply-innervated postsynaptic sites between P15 and adulthood ( Fig. 1B and C) .
Loss of MHCI impairs synapse elimination specifically during the second postnatal week
If MHCI is specifically involved in synapse elimination during the second postnatal week, then acutely disrupting MHCI function during the second postnatal week should cause multiple innervation to persist. To test this hypothesis, we inhibited MHCI function from P7-P15, using an anti-MHCI antibody (OX18) that is function-blocking in multiple assays. Incubating hepatocytes or tumor cells in OX18 is sufficient to trigger lysis by NK cells (Blom et al., 1999; Smits et al., 1994) , a sensitive and specific bioassay for loss of MHCI function. OX18 recognizes MHCI in Western blots and immunohistochemistry from mouse nervous system samples (e.g., (Adelson et al., 2012; Corriveau et al., 1998; Datwani et al., 2009; Dixon-Salazar et al., 2014; Goddard et al., 2007; Huh et al., 2000; Needleman et al., 2010) ). Remarkably, injected antibodies cause a nearly threefold increase in the retention of multiple inputs relative to IgG1-injected littermate controls (Fig. 2) . The quantitatively smaller effect of antibody injection compared to genetic MHCI deficiency is not surprising, for three reasons: (1) antibody penetration may not be complete, resulting in only partial block of MHCI function at the NMJ; (2) antibody is delivered transiently, and may be gradually cleared, resulting in only a temporary block of MHCI function over the week-long experiment; and (3) antibody may not completely block the function of all of the MHCI proteins whose cellsurface expression is reduced in genetically MHCI-deficient mice (see Section 4). The results of these antibody injections show that interfering with MHCI function over the second postnatal week significantly impairs establishment of monoinnervation in WT animals. Since MN cell death and synapse formation were complete before MHCI function was blocked Xu et al., 2006; Yamamoto and Henderson, 1999) , this finding further supports the idea that increased multiple innervation in MHCIdeficient mice is not due to changes in synapse formation, but rather, reflects a disruption of the final stages of synapse elimination.
Classical MHCIs promote synapse elimination at the developing NMJ
If MHCI promotes synapse elimination, then overexpressing MHCI might accelerate synapse elimination. To test this prediction, we compared multiple innervation at P7, when synapse elimination is not yet complete, in WT mice and in mice that overexpress the mouse MHCI H-2D b under the control of the neuron-specific enolase promoter (NSE-D b mice; (Rall et al., 1995) ). At P7, just over half of postsynaptic sites remain multiply-innervated in WT animals. However, a modestly but significantly lower percentage of postsynaptic sites remained multiply-innervated in MHCIoverexpressing animals (Fig. 2C) . The small magnitude of the acceleration may reflect to fact that H-2D b expression is only modestly increased in these transgenics Rall et al., 1995) .
Together, these results demonstrate that developmental synapse elimination at the NMJ can be bi-directionally regulated by changes in MHCI levels: increasing MHCI accelerates synapse elimination, while reducing MHCI disrupts synapse elimination. These results show that overexpressing just one member of the large MHCI gene family, the classical MHCI H-2D b , is sufficient to accelerate synapse elimination at the NMJ. To determine if classical MHCIs are involved in synapse elimination at the developing NMJ, we examined innervation in K bÀ/À D bÀ/À double mutant mice, which lack both of the classical MHCI genes found in C57Bl/6 mice (Vugmeyster et al., 1998) . Both H-2D b and H-2K b genes are expressed at the developing NMJ (Tetruashvily et al., in press) . At P15, the percentage of multiply-innervated postsynaptic sites was three times WT levels in K bÀ/À D bÀ/À mice (multiple innervation 10.6 ± 1.1%, n = 5, p = 0.001 relative to WT). This was not significantly different from b2m
values (p = 0.09), suggesting that loss of H-2K and H-2D could fully explain the initial synapse elimination defects in b2m
of either H-2K or H-2D alone did not affect synapse elimination (Fig 1E) , suggesting that only a single classical MHCI is necessary for normal synapse elimination to occur. Thus three different models that disrupt MHCI function (b2m
and anti-MHCI function-blocking antibodies injected into WT mice) all cause multiple innervation to persist, together strongly suggesting that MHCI promotes synapse elimination at the developing NMJ. Furthermore, results in NSE-D b and K bÀ/À D bÀ/À mice suggest that synapse elimination at the NMJ is promoted by classical MHCI proteins.
MHCI is expressed at the developing NMJ
MHCI protein is not thought to be expressed in uninjured muscle cells, but has been detected in adult MNs at the NMJ (Thams et al., 2009) . mRNAs encoding several MHCI proteins have been detected at the NMJ at multiple ages (Tetruashvily et al., in press ). To determine if MHCI protein is present at the NMJ as synapse elimination is occurring, we immunostained intact muscle using a mouse monoclonal antibody (OX-18) that recognizes a monomorphic epitope of rat MHCI (RT-1A (Fukumoto et al., 1982) ) and reacts with MHCI from rat, mouse and primate brain in Western blots and immunohistochemistry (Corriveau et al., 1998; Datwani et al., 2009; Dixon-Salazar et al., 2014; Goddard et al., 2007; Huh et al., 2000; Needleman et al., 2010; Rolleke et al., 2006) . Several lines of evidence support OX-18's specificity for MHCI in the mouse nervous system (see Section 4). Using OX18, we detect specific MHCI labeling at the NMJ at P7, as synapse elimination is occurring (Fig. S1A ). This labeling is abolished by genetic destabilization of MHCI proteins (in b2m
mice) or by replacing OX-18 with an isotype-control antibody (Fig. S1 ). Whole-mount muscles were triple-labeled with OX18 to label MHCI, a-btx to label postsynaptic nAChRs, and antisynaptophysin to visualize presynaptic MN terminals. Because pre-and post-synaptic structures are closely overlaid at the NMJ, three-dimensional reconstruction of staining in confocal Z-stacks is necessary to unambiguously discriminate co-localization with pre-vs. post-synaptic markers. In P7 diaphragm, MHCI colocalizes more extensively in individual optical sections with postsynaptic nAChRs than with presynaptic synaptophysin (Fig. S1A ). Specific MHCI labeling does not appear throughout the muscle fiber, but is restricted to the postsynaptic site. Thus MHCI protein is expressed at the NMJ at the time when developmental synapse elimination is occurring.
Excess MN inputs can be recruited by graded stimulation in MHCIdeficient mice
Surplus MN inputs are functionally silenced before they are physically removed (Colman et al., 1997; Kopp et al., 2000) . Our results show that MHCI promotes synapse elimination, but it is unclear if MHCI is involved in only the final physical removal of surplus axons, or is involved in the earlier functional silencing. To discriminate between these possibilities, we performed sharp electrode recordings in P15 WT and MHCI-deficient animals, and applied graded stimulation to the phrenic nerve to sequentially recruit MN inputs (Redfern, 1970) . Graded stimulation produced single-amplitude end plate potentials (EPPs) in 100% of recordings from P15 WT animals, as expected, reflecting functional monoinnervation of all postsynaptic sites at this age. In MHCI-deficient animals, in contrast, graded stimulation evoked a large, stepwise increase in the EPP amplitude in 21% of recordings, reflecting recruitment of multiple MN inputs. Multiple inputs could still be recruited at 13% of junctions in MHCI-deficient adults (Fig. 3) . These functional measures independently corroborate the anatomical evidence that synapse elimination is impaired in MHCIdeficient mice, and show that some postsynaptic sites continue to receive inputs from MN axons that are distinct all the way to the phrenic nerve, typical of younger animals before synapse elimination is complete (Redfern, 1970; Tapia et al., 2012) . Thus persistent multiple innervation in MHCI-deficient animals may result from a failure to silence competing terminal branches, rather than a failure to physically remove silent inputs.
Increased synaptic strength at MHCI-deficient NMJs
Competing axons develop a disparity in synaptic strength, and weaker inputs are eventually eliminated (Colman et al., 1997; Kopp et al., 2000) . Our anatomical and functional data support the idea that MHCI promotes silencing and elimination of MN synapses. In the adult hippocampus, MHCI is required for longterm depression, a form of persistent synaptic weakening (Huh et al., 2000; Nelson et al., 2013) . To determine if MHCI is involved in synapse weakening at the developing NMJ, we measured synaptic strength. Quantal size is a measure of synaptic strength that reflects the postsynaptic response to individual quanta of neurotransmitter (Pennefather and Quastel, 1981) . At the NMJ, miniature end plate potential (MEPP) amplitude provides a reliable estimate of quantal size (Del Castillo and Katz, 1954) . MEPP amplitude is significantly larger than WT in MHCI-deficient animals at P15 (b2m
, 1.78 ± 0.14 mV; WT, 1.15 ± 0.16 mV; p = 0.022). Quantal size decreases with age, as previously observed (Wareham et al., 1994) , but remains larger in b2m
, 1.0 ± 0.08 mV; WT, 0.66 ± 0.06 mV; p = 0.004; Fig. S3 ). Increased quantal size in MHCI-deficient NMJs is not associated with changes in input resistance, EPP decay time, MEPP frequency, paired-pulse facilitation (Fig. S4) , postsynaptic nAChR density (Fig. S2) , or the number of quanta released per presynaptic nerve impulse (quantal content) (Fig. S4E) . Together, these results show that loss of MHCI is associated with an early and persistent increase in synaptic strength. Thus endogenous MHCI promotes synaptic weakening at the developing NMJ, and may contribute to the decline in synaptic strength that precedes functional and physical elimination of competing inputs during normal circuit development (Buffelli et al., 2003; Colman et al., 1997; Kopp et al., 2000) .
MHCI levels rise in aged muscle
MHCI mRNA is up-regulated in aged MNs as they become susceptible to denervation (Edstrom et al., 2004) , but is relatively low in MNs that resist aging-related synapse loss (Edstrom et al., 2004; Linda et al., 1999; Valdez et al., 2012) . MHCI promotes synapse elimination at the developing NMJ, raising the possibility that higher levels of MHCI could be involved in aging-related muscle denervation. However, elevated mRNA levels do not guarantee increased transcribed protein levels, and to our knowledge, no studies have assessed MHCI protein levels at the aging NMJ. To determine if MHCI protein levels rise at the aging NMJ as denervation is occurring, we compared MHCI expression in extensor digitorum longus (EDL) from P15 and 2-year-old mice using western blotting. The EDL was chosen because it shows significant denervation at this age (Chai et al., 2011; Valdez et al., 2012) . Because either H2-K or H2-D are required for developmental synapse elimination (Fig. 1E) , we used an antibody (p8) that is specific for H2-K. Values were normalized to a loading control (see Section 4). Comparing MHCI expression in EDL from P15 vs. 2-year-old mice, we found that H2-K levels rise significantly in aging EDL, relative to younger ages (Fig. 4A) . Thus MHCI protein is expressed at the NMJ during development, and MHCI levels rise significantly at the aging NMJ.
MHCI promotes aging-related synapse loss
With aging, synapses are eliminated from mature muscle fibers, leaving some fibers fully denervated (Rudolf et al., 2014; Valdez et al., 2012) . We find that during development, MHCI promotes synapse elimination, and MHCI levels rise in aging EDL, raising the possibility that the increase in MHCI expression with age drives aberrant synapse elimination in mature, singly-innervated muscle fibers. To directly test if MHCI contributes to pathological synapse loss in aging muscle, denervation of EDL muscle fibers was assessed in aged (2-year-old) WT and b2m (labeled with a-btx) are not completely apposed by the nerve terminal, represented by the presynaptic marker SV2 (Valdez et al., 2010) . As expected, a subset of muscle fibers were completely denervated in aged EDL (12.2 ± 0.8% fully denervated, n = 4). In contrast, both full and partial denervation was dramatically reduced in MHCI-deficient EDL ( Fig. 4 ; full denervation 4.5 ± 1.0%, p = 0.0009 relative to WT). While developmental synapse elimination in the EDL was modestly impaired in MHCI-deficient animals (percent multiply-innervated in P15 EDL: WT, 1.0 ± 0.5; b2m
, 5.2 ± 1.1, n = 3 animals per age, p = 0.0045), this difference is not sufficient to fully explain the reduced denervation in MHCIdeficient EDL. Thus the relative lack of denervation in aged MHCIdeficient animals cannot be fully explained by a different starting point for the aging process, but instead reflects a degree of protection from aging-related denervation. Together, these results show that MHCI levels rise with aging at the NMJ, and that reducing MHCI expression can ameliorate synapse loss in aging muscle.
Discussion
Synapse elimination is essential for the establishment of mature neural circuits, while synapse loss later in life is a significant cause of aging-associated pathology. Here we show that MHCI promotes both developmental synapse elimination and aging-related synapse loss at the vertebrate NMJ. MHCI is expressed at the developing NMJ, and three different manipulations that reduce MHCI function-genetic destabilization or deletion of MHCI proteins, or injection of function-blocking anti-MHCI antibodies-cause multiple innervation to persist at otherwise normally-developing synapses. Reducing MHCI expression does not affect patterns of innervation prior to the close of the first postnatal week, suggesting it does not alter earlier synapse formation or elimination. However, synapse elimination during the second week is significantly disrupted, preventing establishment of uniform monoinnervation. Multiply-innervated postsynaptic sites are still present in MHCI-deficient animals at one year of age, are evident both anatomically and functionally, and are associated with increased quantal size. Thus MHCI is required to complete the transition to uniform mono-innervation in developing muscle, and promotes synaptic weakening, one of the earliest hallmarks of competition among multiple inputs to a single muscle fiber. With aging, MHCI levels rise in motor neurons (Edstrom et al., 2004) , and in MHCIdeficient mice, aging-related muscle denervation is markedly reduced.
Several experimental conditions delay synapse elimination at the NMJ, including changes in synaptic activity (Misgeld et al., 2002; Thompson et al., 1979) , NMDAR activation (Personius et al., 2008) , GDNF (Nguyen et al., 1998) , BDNF or its receptor TrkB (Je et al., 2013) , NCAM (Rafuse et al., 2000) , glial neurofascin (Roche et al., 2014) , or PKC theta (Li et al., 2004) . Synapse elimination is also disrupted in mice which bear a dominant-negative mutation in the GARS gene, a mouse model of Charcot-MarieTooth type 2D which includes apparent developmental arrest of NMJ maturation (Sleigh et al., 2014) . Other manipulations, including increasing activity, reducing gap junctional coupling, or loss of the presynaptic glycine transporter GlyT2, accelerate synapse elimination (Bogdanik et al., 2012; O'Brien et al., 1978; Personius et al., 2007) . These and other studies have provided fundamental insights into the molecular and cellular control of the rate of synapse elimination, and suggest factors that may allow synapse elimination to occur normally prior to P7 in MHCI-deficient mice. In some of these models, development of the NMJ is grossly disrupted, which could contribute to their failure to undergo synapse elimination on a normal schedule. While similar gross developmental disruption is not present at MHCI-deficient NMJs, we cannot rule out the possibility that loss of MHCI perturbs synapse elimination indirectly through changes in aspects of development that were not assessed. With most manipulations, however, uniform monoinnervation is still established within the first few postnatal weeks, while multiple innervation is still evident at one year of age in MHCI-deficient mice, suggesting that synapse elimination is persistently disrupted.
We detect MHCI protein at the developing NMJ, where it colocalizes with nAChR labeling, suggesting that it is expressed in the muscle fiber. Importantly, MHCI may also be expressed in the motor neuron and/or Schwann cell during development and/or in aging, a possibility we cannot exclude because there are currently no antibodies to detect most members of the large MHCI family. Multiple MHCI mRNAs are expressed at the NMJ at different ages (Tetruashvily et al., in press ). MHCI protein has been detected in presynaptic motor neurons in adult mice (Thams et al., 2009) , and in human and rat Schwann cells in vitro (Armati et al., 1990; Samuel et al., 1987) . Furthermore, we find that modest overexpression of the MHCI H2-D in neurons (Rall et al., 1995) is sufficient to modestly accelerate synapse elimination (Fig. 2C) . Ultimately, immuno-electron or super-resolution microscopy, coupled with development of dozens of new antibodies, will be necessary to fully characterize the pre-vs. post-synaptic expression of the many MHCI proteins. Nevertheless, the current results show that MHCI is present at the developing NMJ when synapse elimination is occurring.
MHCI is thought to be repressed by healthy muscle cells, and upregulated only after injury, or in disease states (Karpati et al., 1988) . The current results demonstrate an unexpected role for MHCI at the healthy, developing NMJ. Remarkably, MHCI's function at the developing NMJ is strikingly different to its role after injury. Reducing MHCI expression exacerbates loss of synapses made onto axotomized motor neurons (Berg et al., 2013; Oliveira et al., 2004 ), while we find that both developmental and aging-related loss of motor neuron synapses onto muscles are inhibited.
The bulk of excess MN synapses are pruned prior to P7 , but mono-innervation is largely established between P7 and P15, as MNs begin to fire asynchronously (Buffelli et al., 2002; . In MHCI-deficient mice, $15-20% of postsynaptic sites retain two inputs at P15. No postsynaptic sites received three or more inputs at P15 in MHCI-deficient animals, consistent with the fact that very few postsynaptic sites still receive 3 or more inputs at P7 in WTs (Fig. S2F) , the age when MHCI's effects on synapse elimination begin to emerge. The failure of circuit maturation in MHCI-deficient animals is not associated with gross motor defects in mice, but could prevent the emergence of fine-motor control that is behaviorally relevant in humans. Strikingly, the extent of the synapse elimination deficit at the MHCI-deficient NMJ is similar to the extent of axon pruning deficits in the lateral geniculate nucleus of mice lacking MHCI Huh et al., 2000; Lee et al., 2014) , or lacking neuron pentraxin (Bjartmar et al., 2006) or components of the complement cascade (Stevens et al., 2007) . The reason for the partial nature of the pruning failure in the visual system in these models remains unknown. At the NMJ, however, we find that MHCI is specifically required for the final stages of synapse elimination, during the second postnatal week (Fig. 1) . In adult motor neurons, levels of the classical MHCI H-2D appear to be heterogeneous (Thams et al., 2009 ), raising the possibility that different levels of MHCI during development may also render some inputs more susceptible to elimination. Alternatively other factors, including fiber type and associated activity patterns, may influence the role that MHCI plays in elimination of specific axon branches. This is consistent with the finding that MHCI is required for synapse elimination to reach completion in the diaphragm, which consists of a mixture of fast and slow fiber types, but has a smaller influence on synapse elimination in the EDL, which is almost exclusively composed of fast-twitch fibers (Eddinger et al., 1985) . Together, the current results suggest that synapse elimination at the NMJ may be divided into stages with distinct molecular requirements, and that MHCI is essential as the last postsynaptic sites transition from dual-to mono-innervation. During synapse elimination at the NMJ, competing axons develop a disparity in synaptic strength which precedes withdrawal of the weaker input (Colman et al., 1997; Kopp et al., 2000) . While it is unknown if larger synaptic strength at the MHCI-deficient NMJ is related to deficits in synapse elimination, stronger inputs may be less vulnerable to competition-induced synaptic weakening. In this way, loss of MHCI might prevent the development of sufficient disparity in synaptic strength to trigger functional silencing and physical elimination in the most closely-matched competitions.
Interestingly, paired increases in synapse strength and density like those we observe at the MHCI-deficient NMJ are also seen in the cortex (Glynn et al., 2011) and lateral geniculate nucleus (LGN) of MHCI-deficient mice. Additional studies in MHCI-deficient mice found increases in synapse density in cortex , and increased synapse density (DixonSalazar et al., 2014) and strength (Fourgeaud et al., 2010) in hippocampus. While the present study identifies a role for MHCI in synapse elimination at the NMJ, it is as yet unknown if MHCI inhibits synapse formation and/or promotes synapse elimination in cortex or hippocampus.
It will be important to determine if MHCI expression is regulated by activity at the developing NMJ, as it is in the visual system (Corriveau et al., 1998) , to determine if it is specifically responsive to the levels, patterns, and/or synchronization of activity, and to fully define the cellular and molecular networks linking MHCI to changes in the strength and connectivity of synapses. An immunoreceptor for MHCI, PirB, has been detected in the CNS (Syken et al., 2006) , and at the adult NMJ (Thams et al., 2009 ), M.M. Tetruashvily et al. / Brain, Behavior, and Immunity xxx (2016) xxx-xxxbut knocking out PirB does not replicate the failure of retinogeniculate pruning seen in MHCI-deficient mice Huh et al., 2000; Lee et al., 2014; Syken et al., 2006) , suggesting that in the retino-geniculate projection, MHCI promotes developmental synapse elimination via a PirB-independent mechanism.
It remains an open question whether PirB is involved in MHCIdependent changes in synapse number at the NMJ, or in other regions of the CNS, such as hippocampus and cortex. Overall, a detailed molecular mechanistic understanding of MHCI signaling in the nervous system is still lacking. The current study opens the door to advance this critical research at the NMJ, a large, accessible synapse that is uniquely amenable to manipulation and imaging in vivo.
In MHCI-deficient animals, aging-related denervation of EDL muscle fibers is decreased. The characteristic fragmentation or absence of pre-and/or post-synaptic staining at some NMJs in aged animals is unlikely to be due to incomplete labeling, for several reasons: (1) similar discontinuities are never observed in younger muscle; (2) in 2-year-old muscle, most postsynaptic sites are fully labeled; and (3) the percentage of denervated muscle fibers measured in WTs corresponds well with published values for this muscle (e.g., (Chai et al., 2011; Valdez et al., 2012) ). The relative absence of denervation in MHCI-deficient animals cannot be fully explained by the persistence of supernumary inputs and preferential loss of these excess inputs with aging, because developmental synapse elimination, while impaired, is still largely complete at P15 in the EDL in MHCI-deficient animals.
In adults, MHCI levels increase in situations where muscle fiber denervation occurs, including nerve injury, neuromuscular disorders, and normal aging (Edstrom et al., 2004; Emslie-Smith et al., 1989; Thams et al., 2009 ). MHCI expression is notably low in MNs innervating the extra-ocular muscles (EOMs) (Linda et al., 1999) , which are resistant to aging-associated denervation (Valdez et al., 2012) . Here we provide evidence that MHCI protein levels rise at the aging NMJ, and that MHCI promotes denervation of aging muscle. Recent studies also identified a role for MHCI and the MHCI light chain, b2m, in cognitive aging (Smith et al., 2015) . While we find that MHCI is selectively required for the final stages of synapse elimination at the developing NMJ, denervation of aging muscle is almost completely prevented in MHCI-deficient mice, suggesting that vulnerability to aging-related denervation largely depends on MHCI. Together, the current results show that MHCI promotes weakening and elimination of surplus synapses at the developing NMJ, and suggest that aberrant reactivation of MHCIdependent synapse elimination mechanisms may contribute to pathological denervation of adult muscle. They also identify MHCI as a therapeutic target for the prevention of aging-related motor impairments.
Materials and methods
Animal subjects
All experimental protocols were conducted according to the National Institutes of Health (NIH) guidelines for animal research and approved by the Institutional Animal Care and Use Committee (IACUC) at the University of California, San Diego and/or Princeton University. The following mouse strains were used: (1) C57B1/6 wild-type (WT, Harlan/Jackson Labs); (2) mice lacking expression of the MHCI light chain, b2m, as well as the transporter for antigen processing, TAP1, which show greatly reduced stable cell-surface expression of most, but not all, MHCI proteins (b2m
, courtesy of D. Raulet and C.J. Shatz) (Dorfman et al., 1997; Ljunggren et al., 1995) ; (3) mice which 1.2.8 and lack expression of both of the classical MHCI genes present in C57Bl/6, H-2K and
, courtesy of C.J. Shatz) (Vugmeyster et al., 1998) ; (4) mice which lack expression of single classical MHCI genes H-2K or H-2D (K bÀ/À and D bÀ/À , Taconic) (Perarnau et al., 1999) and (5) (Rall et al., 1995) .
Visualization of neuromuscular junctions using
immunohistochemistry and rhodamine-conjugated a-bungarotoxin
Whole mounts of mouse diaphragm muscle were immunostained at P0, P7, P15, P29-50, 12-13 months, or 22-24 months, and mouse EDL was stained at P15 and 22-24 months. Animals were deeply anesthetized using inhaled isoflurane and tissue was drop-fixed with 4% PFA (Electron Microscopy Systems) in phosphate buffered saline (PBS, Sigma) for 30 min. Diaphragm and EDL muscles were dissected, rinsed in PBS, incubated in 0.1% glycine (Fischer) for 12 h at 4°C and then blocked in a solution containing 3% goat serum albumin (GSA, Jackson) and 0.1% Triton X-100 in PBS for 12 h at 4°C, both on rockers. Presynaptic MN terminals were visualized by treating muscles for 48-72 h at 4°C with a primary antibody cocktail consisting of one or both of the following: antineurofilament (Invitrogen, 1:500) and anti-SV2 (developed by K. M. Buckley under the auspices of the NICHD, maintained by The University of Iowa Department of Biology, obtained from the Developmental Studies Hybridoma Bank, 1:100). Tissues were rinsed in PBS for 3x2hrs and then incubated in Alexa-488-conjugated goat anti-mouse IgG (Jackson, 1:100) for 18-24 h at 4°C. Tissues were rinsed in PBS for 3 Â 2 h and treated with rhodamine-conjugated a-btx (Molecular Probes, 10 lg/100 lL) to label postsynaptic nicotinic acetylcholine receptors for 30 min. After a final rinse in PBS, tissues were mounted on slides using fluorescence-stabilizing mounting media (Vectashield hard set mount) and microscopy was performed using a Leica (Wetzlar, Germany) DMI6000 inverted microscope outfitted with a Yokogawa (Tokyo, Japan) spinning disk confocal head and an Orca ER high resolution B&W cooled CCD camera (Hamamatsu, Sewickley, PA). This approach yielded robust immunostaining that allowed clear discrimination of motor neuron axons and presynaptic motor end plates. To ensure maximal antibody penetration, we examined surface fibers at approximately the same depth in all tissues.
Importantly, the appearance of presynaptic immunofluorescence is expected to differ qualitatively from presynaptic fluorescence in mouse lines expressing YFP in a subset of motor neurons, which have been used in many influential studies of the development and denervation of the NMJ (e.g., (Valdez et al., 2010) ). This is because antibodies gradually penetrate the tissue to label specific presynaptic structures (SV2, synaptic vesicles; NF, neurofilament), while YFP is a soluble protein that, when overexpressed in motor neurons, diffuses throughout the presynaptic cytoplasm.
To assess multiple innervation, montages of Z-serial images (<20 lm total thickness per junction) were collected from intact muscles under a 63Â oil immersion lens at 1.6Â magnification. Z-stacks of at least 50 terminals from each hemidiaphragm or EDL muscle (two per animal; each animal was considered an independent n) were examined from each animal at each age by an observer blind to genotype. Junctions were uniformly sampled over the entire dorsal-ventral axis. Innervation was assessed by counting the number of anatomically distinct MN axons contacting each postsynaptic junction, by tracing them back as far as possible in unflattened confocal stacks (5.4-27 lm total depth). In most cases preterminal axons could be followed 50-100 lm from the synapse. Examination of unflattened confocal Z-stacks from multiple depths and angles is necessary to unambiguously distinguish individual MN axons innervating a single postsynaptic site, and to determine if two axons innervate one postsynaptic site, or simply two postsynaptic sites in different focal planes. Junctions in which multiple innervation could not be unambiguously determined (e.g., due to extensive axon fasciculation, variation in labeling intensity, proximity of other nAChR clusters, or depth of axons) were scored as monoinnervated, to ensure a conservative estimate of multiple innervation. Postsynaptic perimeter and area were assessed and quantified using ImageJ software (NIH). For denervation studies in aged EDL, montages of Z-serial images (<20 lm total thickness per junction) were collected from intact muscles under a 63Â oil immersion lens at 1.6Â magnification. Z-stacks of at least 50 terminals from each EDL (two EDLs per animal; each animal was considered an independent n) were examined from each animal by an observer blind to genotype. Junctions were uniformly sampled over the entire muscle. Innervation of a muscle fiber was defined as colocalization of green, SV2-labeled presynaptic axon terminals with a-btx-labeled postsynaptic nAChRs. Both partial and full denervation were scored, as identified as nAChR labeling not fully apposed to presynaptic SV2 labeling, the same criteria used in (Valdez et al., 2010) (Fig. 4) . Most denervated NMJs also showed one or more additional aging-associated changes, including: (1) nAChR fragmentation (>5 nAChR islands; abnormal nAChR cluster shape) and decreased nAChR density (noticeably dimmer a-btx labeling compared to other muscle fibers in the same confocal plane); (2) retraction of the MN axon, multiple innervation, and extra-junctional MN sprouting; and (3) axonal varicosities proximal to the NMJ and axonal atrophy (thinning of the preterminal or terminal axon).
MHCI and synaptophysin immunohistochemistry
Anesthetized P7 WT and b2m
TAP À/À animals were perfused transcardially with 4% PFA. Diaphragms were dissected and stored at 4°C overnight. Muscles were cleaned of connective tissue and blocked in a solution containing 5% bovine serum albumin, 0.01% Triton X-100 and 0.1% sodium azide (Fischer) for one hour. Muscles were treated with primary antibodies against synaptophysin (SYPH, Santa Cruz, 1:100) and MHCI (OX18, AbdSerotec, 1:100) overnight at 4°C. OX18 is a mouse monoclonal antibody that recognizes a monomorphic epitope in the a3 region of the rat MHCI RT-1A (Fukumoto et al., 1982) , and reacts with mouse MHCI in Western blots and immunohistochemistry (Corriveau et al., 1998; Datwani et al., 2009; Dixon-Salazar et al., 2014; Goddard et al., 2007; Huh et al., 2000) . The suspected mouse orthologue of rat RT-1A, H-2K1, is 84.9% identical and 89.2% similar to RT-1A at the amino acid level in the a3 region, the site of the OX-18 epitope.
Several lines of evidence support OX-18's ability to bind to MHCI in the mouse nervous system. First, genetically deleting the MHCI light chain, b2m, reduces the amount of MHCI that reaches the cell surface (Dorfman et al., 1997; Zijlstra et al., 1989) , and cell surface OX-18 immunofluorescence is greatly attenuated in both b2m Needleman et al., 2010) and b2m Goddard et al., 2007) neurons in vitro. Second, OX-18 recognizes proteins of the expected molecular weight in western blots of adult mouse brain (Corriveau et al., 1998; Dixon-Salazar et al., 2014; Huh et al., 2000) and similar labeling is seen in rat brain using a rabbit polyclonal antibody that recognizes a distinct epitope of MHCI (Needleman et al., 2010) . The secondary antibodies we used to detect MHCI cause some nonspecific background labeling, which can be clearly distinguished from specific labeling in two ways:
(1) it is still present when labeling with an isotype-control antibody, and (2) it is not abolished in MHCI-deficient animals (Fig. S1 ). Using these criteria, specific MHCI labeling is present at the postsynaptic site, while other muscle labeling is nonspecific. Taken together, these results provide strong support for the specificity of OX-18 in recognizing MHCI at the mouse NMJ.
Incubation in primary antibody was followed by 3 Â 40 min rinses in PBS, and a four hour treatment with the appropriate cocktail of Alexa-488-conjugated donkey anti-mouse IgG (Invitrogen, 1:1000) and/or Cy5-conjugated donkey anti-goat IgG (Jackson, 1:100) in block. After rinsing 3 Â 40 min, muscles were treated for 30 min with rhodamine-conjugated a-bungarotoxon (a-btx) diluted 1:10 in ddH 2 O. Samples were rinsed in 3 Â 20 min in PBS, mounted on glass slides, and coverslipped using Vectashield hardset mount. Coverslipped slides were sandwiched between two pieces of paper towel and compressed under a lead brick overnight, edges sealed with clear nail polish, and stored at 4°C until imaging.
Z-serial images (0.5 lm per step, up to 20 lm total depth per junction) were collected from intact muscles using a Leica (Wetzlar, Germany) DMI6000 inverted microscope outfitted with a Yokogawa (Tokyo, Japan) spinning disk confocal head and an Orca ER high resolution B&W cooled CCD camera (Hamamatsu, Sewickley, PA) under a 63Â oil immersion lens at 1.6Â magnification. WT and b2m À/À TAP À/À samples were imaged under identical conditions during the same microscopy session.
Western blotting
EDL muscles were dissected as above from P15 and aged (2 year old) WT mice (2 animals per age). Pooled tissue for each age was suspended in 500 ll of lysis buffer (50 mM NaH 2 PO 4, 300 mM NaCl , 10 mM imidazole , 1% NP-40 , 0.5% TritonX-100 , Halt protease and phosphatase inhibitor (Pierce, Rockland, IL) and flash-frozen in liquid nitrogen. Frozen tissue was placed in pre-cooled 50 ml grinding jars along with a 20 mm stainless steel ball bearing and subjected to cryogenic grinding in liquid nitrogen for 20 min at 25 Hz on a Retsch CryoMill until rendered into a fine powder. Total protein concentration in the samples was determined using a NanoDrop ND-1000 UV-Vis spectrophotometer from Thermo (absorbance (A280) was measured). Samples (40, 80, or 160 lg/lane) were subjected to SDS-PAGE using 4-20% Mini-PROTEAN Ò TGX TM gradient gels from BIORAD, and transferred to a PVDF membrane.
Membranes were blocked for 1 h at room temperature (RT; $25°C) in 5% organic dry milk in TBST. Primary antibodies (anti-MHCI [p8, 1:500, purified rabbit polyclonal raised against exon 8 of H-2K, GeneScript] or anti-GAPDH [MAB374, 1:5,000, purified mouse monoclonal raised against rabbit GAPDH, EMD Millipore]) were diluted in blocking buffer and incubated with the membranes overnight at 4°C (p8) or 1 h at RT (GAPDH). Membranes were washed 12 Â 5 min in TBST, followed by 1 h incubation at RT with the appropriate HRP-conjugated secondary antibody (for MHCI: goat anti-rabbit HRP [1:5,000] from Jackson ImmunoResearch Laboratories, product #111:035:144; for GAPDH: goat anti-mouse HRP [1:10,000] from ThermoFisher, product #A24512). Membranes were washed 12 Â 5 min in TBST and labeling detected using either Pierce ECL Western Blotting Substrate (Pierce, Rockland, IL catalog # 32106) (for GAPDH) or SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockland, IL catalog # 34080) (for MHCI) and used to expose HyBlot CL Autoradiography Film (Denville Scientific, Metuchen, NJ). Blots were first probed for MHCI, and then stripped and reprobed for GAPDH. Blots were stripped using a mild stripping solution (1L of water containing 15 g glycine, 1 g SDS, 10 ml Tween 20, pH 2.2) heated to 55°C. Blots were incubated in 20 ml of stripping solution for 10 min, washed 12 Â 5 min in TBST, and blocked and processed as above for the second antibody (anti-MHCI).
Electrophysiology
Hemidiaphragm-phrenic nerve preparations were used from WT and b2m À/À TAP À/À animals at P14-16 and adult (P29-P45) ages.
Muscles were dissected from anesthetized animals under cold, oxygenated (95% CO 2 /5% O 2 ) Rees normal mammalian ringers (NMR; (Rees, 1978) ) consisting of (in mM): 135 NaCl, 5 KCl, 15 NaHCO 3 , 1 Na 2 HPO 4 , 1 MgSO 4 , 2.5 Ca gluconate, and 11 glucose, pH 7.4. Contraction blockade, which is necessary to permit microelectrode recordings from postsynaptic muscle fibers, was achieved via 1 h pretreatment of diaphragms in oxygenated 2 lM l-conotoxin (Bachem) (adult muscles) or 3-6 lM tubocurare (P15). Muscles were pinned to a Sylgard-lined recording chamber and superfused (1 mL/min) with oxygenated NMR at 22-24°C. Intracellular recordings of muscles fibers were performed using sharp recording electrodes (30-69 MX) filled with 3 M KCl. End plate potentials (EPPs) were evoked via suprathreshold stimulation of the phrenic nerve with a suction electrode (square pulses, 0.2 ms duration at 0.5 Hz). Electrodes were visually guided to NMJs under oblique illumination. Responses with rise times of more than 1.5 ms represent electrode placements relatively distant from the junction, and were discarded. Membrane potentials were continuously recorded and only muscle fibers in which potentials were <À55 mV and stable within ±5 mV were included in analysis. Membrane responses were amplified by an Axoclamp 2A amplifier (Axon Instruments), low-pass filtered at 1 kHz, and digitized and recorded using WinWCP software (John Dempster). Levels of innervation were assessed electrophysiologically by applying graded stimulation to the phrenic nerve stump and counting the number of elicited inputs of differential amplitude above normal quantal variability. Miniature end-plate potentials (MEPPS) were recorded in gap-free mode from singly-innervated junctions and analyzed offline using MiniAnalysis software (Justin Lee; Synaptosoft). For quantal content analysis, EPPS were evoked and MEPPs were recorded for two seconds following stimulation at singly-innervated junctions. Quantal content was estimated as the ratio of the mean EPP amplitude to the mean MEPP amplitude (Wood and Slater, 2001 ).
Antibody injections
P7 WT mice received daily intraperitoneal injections for 7 days with 10 lg/g body weight of either panspecific anti-MHCI antibody (OX18; AbdSerotec) or isotype-matched mouse IgG1 control (AbdSerotec). While injecting one specific antibody against H-2 d , can induce a model of transfusion-induced lung injury in rats (Looney et al., 2006) , nine other anti-MHCI antibodies, including OX18, do not induce this model (Kelher et al., 2009; Strait et al., 2011) . P15 mice were perfused and diaphragms were either immunostained for neuromuscular morphology as described above, or treated with Alexa 488-conjugated goat anti-mouse IgG1 (Invitrogen, 1:100) for four hours to visualize OX18 or IgG1 binding.
Data analysis
All immunohistochemical experiments were collected and analyzed blind to genotype. Data are presented as mean ± standard error of the mean. p Values determined by unpaired one-tailed Student's t-test. Unless otherwise noted, asterisks indicate p < 0.05, and n = number of animals.
